These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride. Kopecek M; Bares M; Horácek J Neuro Endocrinol Lett; 2005 Aug; 26(4):320. PubMed ID: 16136015 [No Abstract] [Full Text] [Related]
9. Aripiprazole in a patient vulnerable to side effects. Dehning S; Riedel M; Müller N Am J Psychiatry; 2005 Mar; 162(3):625. PubMed ID: 15741488 [No Abstract] [Full Text] [Related]
10. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period. Joyce JN Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025 [TBL] [Abstract][Full Text] [Related]
11. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study. Müller MJ; Regenbogen B; Sachse J; Eich FX; Härtter S; Hiemke C Pharmacopsychiatry; 2006 Mar; 39(2):41-6. PubMed ID: 16555163 [TBL] [Abstract][Full Text] [Related]
12. Galactorrhea with aripiprazole. Mendhekar DN; Andrade C Can J Psychiatry; 2005 Mar; 50(4):243. PubMed ID: 15898468 [No Abstract] [Full Text] [Related]
13. Two cases of amisulpride overdose: a cause for prolonged QT syndrome. Ward DI Emerg Med Australas; 2005 Jun; 17(3):274-6. PubMed ID: 15953230 [TBL] [Abstract][Full Text] [Related]
14. Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons. Di Giovanni G; Di Mascio M; Di Matteo V; Esposito E J Pharmacol Exp Ther; 1998 Oct; 287(1):51-7. PubMed ID: 9765321 [TBL] [Abstract][Full Text] [Related]
15. Development of tardive dyskinesia in a patient taking amisulpride. Masdrakis VG; Papadimitriou GN; Papageorgiou C; Kouzoupis A; Giailoglou D; Soldatos CR Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):586-7. PubMed ID: 17196725 [No Abstract] [Full Text] [Related]
16. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature. Zink M; Knopf U; Henn FA; Thome J Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045 [TBL] [Abstract][Full Text] [Related]
17. Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulpride. Opgen-Rhein C; Neuhaus AH; Dettling M J Clin Psychopharmacol; 2007 Feb; 27(1):92-3. PubMed ID: 17224723 [No Abstract] [Full Text] [Related]